Fresenius 4Q Rev EUR5.68B: Net Loss Due to Medical Care Deconsolidation

Fresenius Reports Net Loss for Fourth Quarter

Fresenius, a German health-care company, has reported a swing to a net loss for the fourth quarter of 614 million euros. The loss is mainly attributed to the deconsolidation of Fresenius Medical Care from its accounts, although it had no cash impact. However, the company remains optimistic about its future growth, forecasting increased earnings and sales for 2024.